Search bioRxiv⌕ Search

Biology subjects

Chu, C. M. J.

Publications and source records attributed to Chu, C. M. J..

2 recordsLinked to original sources

Functional, transcriptomic, and proteomic profiles of human primary and stem cell-derived beta cells in a state of high insulin production and increased fragility

Insulin production is a cardinal feature of pancreatic {beta} cells. Studies in rodents show that {beta} cells can switch between low and high insulin gene activity states and that elevated insulin production makes {beta} cells more vulnerable to stresses associated with diabetes. In people, genetically elevated insulin production increases the risk of type 1 diabetes. Via effects on obesity, hyperinsulinemia contributes to the pathogenesis of type 2 diabetes. Here, we characterize {beta} cells in low and high INS gene activity states sorted from primary human islets transduced with INS-GFP adenovirus and differentiated INS-EGFP knock-in embryonic stem cells (SC{beta} cells). We profile {beta} cell function, protein synthesis, resilience to diabetes associated stress, single {beta} cell transcriptomes and their co-activity networks, and purified {beta} cell proteomes. We show that human {beta} cells transition between distinct states. High INS cells have elevated maturity marker mRNAs and proteins, increased protein translation, are larger, but also more susceptible to cell death when exposed to diabetes-relevant stresses. We also catalogue thousands of differences in proteins in high INS stem cell-derived {beta} cells compared directly with high INS primary {beta} cells. Our study improves our understanding of the delicate balance between insulin production and {beta} cell resilience and guides the engineering of better {beta} cells. Blurbtranscriptional, proteomic, and functional analyses of insulin gene expression states in human {beta} cells from donor islets and stem cells Key findingsO_LIWe identify high and low INS gene activity states in human insulin-producing cells from donor islets and embryonic stem cell differentiations. C_LIO_LIWe characterize the relationship between insulin production and fragility, demonstrating that increased insulin production comes at a cost of reduced resilience to multiple stresses. C_LIO_LIFunctional, transcriptomic, and proteomic analyses identify similarities and differences between how primary and stem cell-derived {beta} cells manage stress and insulin production. C_LIO_LIWe report a comprehensive side-by-side proteomic analysis of purified primary and stem cell- derived {beta} cells in the high INS state and identify differences in protein production and secretion machinery, providing a roadmap for making better {beta} cells. C_LI

physiology↗

A prioritized medium-throughput screen on human stem cell derived insulin secreting beta cells identifies FGF4, FGF5, FGF8F, FGF19 and FGF21 as protective factors

AbstractStem cell-derived {beta}-like cells (SC{beta} cells) are a potential alternative to cadaveric {beta} cells for replacement therapy in type 1 diabetes. However, SC{beta} cells face a multitude of stresses that must be overcome. Both {beta} cells and SC{beta} cells reside in complex microtissues and can therefore be modulated by hundreds of autocrine/paracrine signals within these islets or spheroids. Here, we leveraged multi-omics data from late-stage SC{beta} cells and human islets to map ligand-receptor pairs and generate a prioritized list of ligands for high-content SC{beta} cell survival screening. Our medium-throughput screen tracked cell number, cell death, and INS production over several days using automated, high-content imaging. Members of the fibroblast growth factor (FGF) family significantly prevented cytokine-induced cell death, with the top validated hits being FGF4, FGF5, FGF19, FGF21, and FGF8F. With these results, there is the potential to improve SC{beta} cell survival in vitro via readily targetable pathways and to produce a more robust product for translation to the clinic.

molecular biology↗